Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > Stocks to Watch 2

<< Previous

Bullboard Posts

Next >>

Comment by annegelon Jan 22, 2018 8:34pm

91 Views

Post# 27412301

RE:Stocks to Watch 2

Looks like this acquisition was part of the $1.95 a share valuation : This acquisition was anticipated and was an important driver of NAPEC's Board of Directors' valuation of the Corporation," said Pierre L. Gauthier, President and Chief Executive Officer of NAPEC.

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions